Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: would any on board lawyers know?
Wolfpackvolt, thanks for the very informative post. I found it interesting that it states here there are recurring revenues. At the SHM I recall it being stated that PTSC just wanted lump sums. They didn't want complicated and costly accounting work to track quarterly income. More employees and more chance of cheating. I personally like the idea of quarterly revenue. I now wonder if this is the only deal with recurring revenues or are there others like it. Maybe it depends on the deal and how the coin lands in the negotiations. There are so many posts that I can't keep up with them all. GLTAL on Monday and through out this week, Oct. and the rest of the year! PTSC is in a way better place than it was last year IMO.
Share
New Message
Please login to post a reply